| Bioactivity | Olmutinib hydrochloride is an orally active and irreversible third EGFR tyrosine kinase inhibitor that binds to a cysteine residue near the kinase domain. Olmutinib hydrochloride is used for NSCLC[1][2]. |
| CAS | 1842366-97-5 |
| Formula | C26H28Cl2N6O2S |
| Molar Mass | 559.51 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kim ES, et al. Olmutinib: First Global Approval. Drugs. 2016 Jul;76(11):1153-7. [2]. Mohamed W. Attwa, et al. Detection and characterization of olmutinib reactive metabolites by LC‐MS/MS: Elucidation of bioactivation pathways. Journal of Separation science. 18 November 2019. |
Olmutinib hydrochloride
CAS: 1842366-97-5 F: C26H28Cl2N6O2S W: 559.51
Olmutinib hydrochloride is an orally active and irreversible third EGFR tyrosine kinase inhibitor that binds to a cystei
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.